Infinity and MEI scrap merger after unsolicited bid, lack of shareholder support
Infinity Pharmaceuticals and MEI Pharma axed their all-stock merger after the latter received a lack of shareholder support following an unsolicited proposal from activist investors …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.